CLINICAL_TRIALS
withdrawal
· 2015-01-15
Clinical Trial Update: A Phase 2 Extension of Study GCS-100-CS-4003 [Phase 2]
Summary
A Phase 2 extension study (GCS-100-CS-4003) for chronic kidney disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: La Jolla Pharmaceutical Company | Conditions: Chronic Kidney Disease | Phase 2 | Status: WITHDRAWN